BRÈVE

sur Microbix Biosystems Inc. (CVE:MBX)

Microbix Launches New Product Category in Life Sciences

Microbix Biosystems Inc., a Canadian life sciences company, has begun sales of its custom biological materials. These materials are designed for incorporation into assays or test cartridges of in-vitro diagnostics manufacturers. Two manufacturers have already started integrating Microbix materials into their new assays.

The company provides materials that act as sample processing controls (SPCs) in laboratory and point-of-care diagnostics. SPCs ensure the functionality of critical assay stages such as nucleic-acid extraction and detection. This development is expected to generate recurring sales as more manufacturers adopt these components.

Microbix's new offerings support both DNA and RNA-based assays, enhancing its existing product lines. The company aims to secure further clients and expand its market reach in the diagnostics industry.

R. H.

Copyright © 2026 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.

Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève

Voir toutes les actualités de Microbix Biosystems Inc.